Lord Mayor opens York’s first dedicated clinical research site

The UK’s largest Site Management Organisation (SMO), Panthera Biopartners, has opened the first dedicated clinical research site in York. The site, which has been operating since May, was officially opened by the Lord Mayor of York, Councillor Margaret Wells, at an opening ceremony on 25th July 2024. The clinic is …

Read more

International Clinical Trials (ICT): Panthera interview

International Clinical Trials (ICT): Panthera interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials Panthera’s Ian Smith and Chris Dodd recently spoke to ICT about the differences in private versus public clinical trials, how speed is key in preclinical processes and how …

Read more

Why take part in research?

What is a clinical trial? The first recorded planned clinical trial was conducted by Dr. James Lind, a Scottish naval surgeon. In 1747, Lind began to study scurvy, which killed thousands of British sailors per year. Lind tested the diet of citrus fruit to a select group of affected sailors, …

Read more

Panthera partnership with Preston North End Community Trust

Panthera have formed a partnership with Preston North End Football Club Community Trust. The team at Panthera attended the PNE vs Birmingham City game on the 15th of January promoting clinical trials. Fans who visited the Panthera van on game day also learnt more about additional clinical trials, such as those aimed …

Read more

Valneva vaccine clinical trial, phase 3 results

Valneva have released results from their phase 3 vaccine study (VLA2001). Stating that the trial has successfully met both co-primary end points. This trial compared the efficacy and effectiveness of the Valneva Covid-19 vaccine against the AstraZeneca vaccine. A total of 4012 people, aged 18 years and above were recruited …

Read more

Clinical trial specialist Panthera Biopartners has appointed corporate financier Christopher Steed as a non-executive director to continue its expansion both in the UK and overseas

Independent clinical trial site management organisation (SMO), Panthera Biopartners, has appointed M&A and fundraisings adviser Chris Steed as a non-executive director. Chris has over 25 years’ experience as a corporate financier, working at Arthur Andersen, Deloitte and for the past 17 years as Founder and Managing Partner of Argyll Partners. Chris …

Read more

Panthera adapts for COVID-19 virus – Letter from Stuart Young, CEO

As we all continue to adapt to the COVID-19 pandemic, we at Panthera are closely monitoring this rapidly evolving situation as well as remaining vigilant to support our patients and the NHS in any way we can. Panthera sites will remain open for business with significant additional precautions to prevent …

Read more